USCA | USCA

Study shows patients who switched from treatment with a ritonavir-boosted protease inhibitor maintained virologic suppression, experienced improved lipid profiles, and suffered fewer side effects.

New insurance protections, changes in how AIDS Drug Assistance Program benefits are counted, Medicaid expansion, and other provisions in the law will mean better care for many patients.

A unique program that focuses on specific neighborhoods in Philadelphia with high hepatitis C and HIV/AIDS infection rates provides free testing, works with local leaders to destigmatize testing, and connects infected individuals with needed health care services.

Researchers have had little success in developing an HIV cure, but recent studies involving gene therapy, immune-based therapy, reactivation of the immune system, and "very early" treatment have produced promising results.

Due to improvements in treatment and other factors, the number of HIV-positive patients over age 50 is growing rapidly. With their greater risk for serious comorbidities such as depression and addiction, these patients represent a unique challenge for clinicians and caregivers.

News and updates about USCA 2013.